Something doesn't smell right in Denmark. Timeline: they get notice of delisting on the 17th, interim release of bogus data on the 21st, stock goes up to $1.23 the morning of the 22nd, and falls down to the 0.80's and King posts the SEC filing for delisting on the 22nd afternoon. A lot of shares were bought at $1.23...I wonder who. Gives pharma companies a bad name. Dead and buried. I hope the SEC is looking into this!
It's all in the study design. Placebo control versus a known drug...of course there will be positive results. And who, other than someone wanting to dump stock, would release interim study results. I am sure there will be an investigation on who the big seller was at $1.23. Don't worry, this is still a dead company with nothing to offer and no buyers..
So how much is ALXA going to pay Teva to reacquire the product. Plus, what about the note Teva is carrying for ALXA. Oppps there goes my Kurig machine. Surprised this hasn't sunk the ship or voluntary delisting.
Only activity at end of October is liquidation sale to increase revenue for earnings call. CFO gone, only people left were promoted to VP, good resume building credentials. Google will pay premium for the space...oh, forgot what about manufacturing...oh, there is no manufacturing...never mind.
Good concept..#$%$ poor strategy and execution.
No buyer...see latest announcement for selling assets. I'm ready to buy their Kurig machine. About the only item of value.
Agree..another win-win. Does anyone know the projected revenue for this new indication? Have clinicians been using their judgment on the potential uses for this therapy?
"The party's over...turn out the lights"...I love the Q10 statement about how hard it is to find talented executives, and why ALXA should be thankful to have Thomas King...I wonder who wrote that?
Check back tomorrow afternoon. See if the Grim Reaper will visit the conference call. Should be a quick earning announcement...nothing coming in, everything filling Exec's pockets.
Any updates, other than rubber stamping the board and new accountant firm. Glad to see compensation was also approved. Really, what was said and done at the meeting, other than final farewells.
Gentlemen and Cooper,
Please keep to the facts. Let's not take things personal. If you don't like the facts, then that is your problem. If the facts are wrong, then post something to dispel them. As my granddaddy told me: A coward shoots with his eyes closed.
Well, it was fun while it lasted. What's the odds of King pulling a rabbit out of his hat to get the value of the stock about $35 million. Filing today gives them 6 months and maybe a petition before delisting. So who is going to turn the lights out on the message board.
There is no more manufacturing...period. They are closing up shop in 30 days. Layoffs to preserve capital. Their biggest obligation, MAH in Europe, was transferred. There really isn't anything to do. It will take years to get approval for a new manufacturing facility, and that is only possible if their creditors are paid. Does anyone see value in the IP??
Amazing what the BoD could do!! More amazing that they didn't do anything to save the ship long ago (e.g., change in management). Cronyism is the only word that comes to mind. Someone should re-read by-laws about changes in accounting firms. Interesting write-up in the SEC filing...sounds like someone is hiding something!?!?
Just like the Titanic! Time to jump ship! Other than people speculating on pennies, please show us how ALXA is turning around? Future orders? Excellent pipeline? Remember it wasn't the iceberg that the captain saw that sank the Titanic; what wasn't seen did the damage. Its a matter of where you look
See the smoke signals: ALXA management team should start developing resume building skills, grow a set of balls and do the right thing...transparent communication. The COO (who supposedly left on his own volition) comes out clean..i couldn't take the BS, and left!. The Reg guy (Ed) was promoted to a position that is similar to the guy who cleans up after the elephants during the circus parade. That is the only role required by the FDA.
I had a chance to get into ALXA years ago, but did enough research not to buy into the BS. Kiss away the ALXA IP; The big and mighty (e.g., Allergan/Activius) tried inhalation drug delivery with no success. The only return would be through a fire sale. And as I stated earlier, they might collect more money from insurance.
The real problem is Corporate transparency and the lack of integrity at the Board level. Unfortunately the shareholder have no voice, as the institutional buyer votes with the existing board( BTW, ALXA has less that 25% institutional buyers....Ferrar must own a lot). It's now just a matter of how big a tax loss you need. I have a tax guy to help you.
No value in IP. Unless you were a pharma company requiring pulmonary delivery for your drug to work....and you tried everything else. The REMS is platform based, nothing to do with the drug.
Office furniture, coffee maker were cheap...maybe $10K
Manufacturing assets..0, nada...only if you wanted to manufacture the device. At best, pennies on the dollar.
Inventories: Obviously Teva didn't want it..short dated product..will collect more dust before they expire.
Good luck on a fire sale...maybe collect more on the insurance.